WQ
NVO

Wealth Quarterback’s Novo Nordisk NVO Stock Holding History

Wealth Quarterback’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$893K Buy
18,626
+519
+3% +$22.3K 0.28% 62
2026
Q1 		$665K Buy
18,107
+2,298
+15% +$109K 0.26% 70
2025
Q4 		$804K Sell
15,809
-4,605
-23% -$235K 0.29% 61
2025
Q3 		$1.13M Buy
20,414
+598
+3% +$35K 0.44% 46
2025
Q2 		$1.37M Buy
19,816
+3,795
+24% +$258K 0.65% 36
2025
Q1 		$1.11M Buy
16,021
+3,660
+30% +$302K 0.63% 35
2024
Q4 		$1.06M Buy
12,361
+5,174
+72% +$560K 0.5% 42
2024
Q3 		$856K Buy
+7,187
New +$958K 0.45% 50
2021
Q3 		$45K Buy
924
+264
+40% +$12.8K 0.03% 254
2021
Q2 		$28K Buy
+660
New +$25.6K 0.02% 304
2020
Q2 		– Sell
-644
Closed -$19.4K – 543
2020
Q1 		$19.4K Sell
644
-100
-13% -$2.98K 0.02% 342
2019
Q4 		$21.5K Buy
+744
New +$20.6K 0.02% 339

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wealth Quarterback's NVO Position: Q2 2026 in Review

Wealth Quarterback increased its Novo Nordisk (NVO) stake by 2.9% in Q2 2026, buying an estimated $22.3K and bringing the position to 18,626 shares worth $893K. The position accounts for 0.28% of the portfolio, ranked #62.

Wealth Quarterback first reported a position in NVO in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.37M in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Wealth Quarterback held 18,626 shares of Novo Nordisk worth $893K as of Q2 2026.
  • Wealth Quarterback bought 519 Novo Nordisk shares in Q2 2026, an estimated $22.3K.
  • Novo Nordisk made up 0.28% of Wealth Quarterback's portfolio in Q2 2026, its #62 holding.
  • Wealth Quarterback first reported a position in Novo Nordisk in Q4 2019 and has held it in 12 quarters since.
  • Wealth Quarterback's Novo Nordisk position peaked at $1.37M in Q2 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Wealth Quarterback's 13F filing for Q2 2026, filed 27 Jul 2026.